We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Congenital mesoblastic nephroma is characterised by kinase mutations including EGFR internal tandem duplications, the ETV6–NTRK3 fusion, and the rare KLHL7–BRAF fusion.
- Authors
Zhao, Manli; Yin, Minzhi; Kuick, Chik Hong; Chen, Huiyi; Aw, Sze Jet; Merchant, Khurshid; Ng, Eileen Hui Qi; Gunaratne, Sandini; Loh, Amos Hong Pheng; Gu, Weizhong; Tang, Hongfeng; Chang, Kenneth Tou En
- Abstract
Aims: Congenital mesoblastic nephroma (CMN) is histologically classified into classic, cellular and mixed subtypes. The aims of this study were to characterise the clinical, pathological and molecular features of a series of CMNs, and to determine the utility of pan‐Trk and epidermal growth factor receptor (EGFR) immunohistochemistry as surrogate markers for NTRK gene fusions and EGFR internal tandem duplications (ITDs). Methods and results: Twenty‐two archival CMN cases (12 classic, five cellular, and five mixed) were tested for the ETV6–NTRK3 fusion and EGFR ITD transcripts by the use of reverse transcriptase polymerase chain reaction (PCR), and next‐generation sequencing‐based anchored multiplex PCR. All 12 classic CMNs had EGFR ITD. Of the five cellular CMNs, four had the ETV6–NTRK3 fusion and one had the KLHL7–BRAF fusion. Of the five mixed CMNs, four had EGFR ITD, and one had the ETV6–NTRK3 fusion. Pan‐Trk immunoreactivity was 100% sensitive and 94.1% specific for the presence of NTRK rearrangement. However, EGFR staining was only 62.5% sensitive and 33.3% specific for EGFR ITD. Conclusions: EGFR ITD is a consistent genetic event in classic CMN. A majority of cellular CMNs have the ETV6–NTRK3 fusion. Rare cellular CMNs may harbour non‐canonical mutations such as the KLHL7–BRAF fusion, which was found in one case. Mixed CMNs may have either EGFR ITD or the ETV6–NTRK3 fusion. Pan‐Trk immunohistochemistry is a sensitive, albeit not perfectly specific, marker for NTRK rearrangement. EGFR immunohistochemistry is not helpful as a marker of EGFR ITD.
- Subjects
REVERSE transcriptase polymerase chain reaction; ANAPLASTIC lymphoma kinase; EPIDERMAL growth factor receptors; BIOMARKERS
- Publication
Histopathology, 2020, Vol 77, Issue 4, p611
- ISSN
0309-0167
- Publication type
Article
- DOI
10.1111/his.14194